Jump Financial’s Direxion Daily S&P Biotech Bear 3X ETF LABD Stock Holding History

Jump Financial’s Portfolio LABD Stock Details LABD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$804K	Buy	+104,314	New	+$1.4M	0.01%	1279
2026 Q1	–	Sell	-140,817	Closed	-$2.97M	–	2168
2025 Q4	$2.97M	Buy	+140,817	New	+$3.82M	0.04%	536
2025 Q3	–	Sell	-17,424	Closed	-$1.3M	–	2027
2025 Q2	$1.3M	Buy	17,424 +9,033	+108%	+$799K	0.01%	870
2025 Q1	$791K	Buy	8,391 +3,380	+67%	+$247K	0.01%	911
2024 Q4	$363K	Buy	+5,011	New	+$307K	0.01%	1230
2024 Q1	–	Sell	-7,572	Closed	-$734K	–	2111
2023 Q4	$734K	Sell	7,572 -28,216	-79%	-$5.49M	0.02%	867
2023 Q3	$7.37M	Buy	35,788 +2,135	+6%	+$347K	0.27%	56
2023 Q2	$4.84M	Buy	33,653 +27,966	+492%	+$4.18M	0.18%	121
2023 Q1	$1.17M	Sell	5,687 -7,393	-57%	-$1.26M	0.05%	533
2022 Q4	$2.26M	Buy	13,080 +3,020	+30%	+$619K	0.12%	237
2022 Q3	$2.41M	Buy	10,060 +6,072	+152%	+$1.41M	0.09%	320
2022 Q2	$1.55M	Buy	+3,988	New	+$2M	0.07%	412

Other funds holding LABD

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Squarepoint New York $90.5B AUM 33.95% 1-Year Est. Return

Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return

XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return

TSS

Two Sigma Securities New York $1.16B AUM 36.23% 1-Year Est. Return

GTS Securities Miami, Florida $4.75B AUM 41.97% 1-Year Est. Return

Jump Financial's LABD Position: Q2 2026 in Review

Jump Financial opened a new position in Direxion Daily S&P Biotech Bear 3X ETF (LABD) in Q2 2026: 104,314 shares worth $804K. The stake represents 0.01% of the portfolio and ranks #1279 among its holdings. This is a return to the name: Jump Financial previously reported a position in LABD as recently as Q4 2025.

Jump Financial first reported a position in LABD in Q2 2022 and has held it in 12 quarters since. The position peaked at $7.37M in Q3 2023. 21 funds tracked by Wall St. Rank hold LABD as of Q2 2026.

Jump Financial held 104,314 shares of Direxion Daily S&P Biotech Bear 3X ETF worth $804K as of Q2 2026.
Direxion Daily S&P Biotech Bear 3X ETF was a new Jump Financial position in Q2 2026.
Direxion Daily S&P Biotech Bear 3X ETF made up 0.01% of Jump Financial's portfolio in Q2 2026, its #1279 holding.
Jump Financial first reported a position in Direxion Daily S&P Biotech Bear 3X ETF in Q2 2022 and has held it in 12 quarters since.
Jump Financial's Direxion Daily S&P Biotech Bear 3X ETF position peaked at $7.37M in Q3 2023.
21 funds tracked by Wall St. Rank held Direxion Daily S&P Biotech Bear 3X ETF as of Q2 2026.

Based on Jump Financial's 13F filing for Q2 2026, filed 13 Aug 2026.